Sanguine Announces Significant PHER-O2 Order

27 July 2010, 3:06 am

PASADENA, CA--(Marketwire - July 27, 2010) - Sanguine Corporation ( OTCBB : SGUI ), a bio-pharmaceutical company developing products for use in biomedical and medical device applications, announces that the Company has recently received a significant order from Virginia Commonwealth University (VCU) for PHER-O2, the Company's ultra-oxygen carrying perfluorocarbon-based product. The University is ...... Read More »

More Topics from "News"

• Human Society will offer low-cost pet vaccinations
• Cassini Helps With Dune Whodunit
• Kiffin thinks Titans' lawsuit is due to his Tennessee history
• OpenTable Announces Winners of 2010 Diners' Choice Awards for Most Kid-Friendly Restaurants
• Peterson, Woodside share winners circle at Orange Show Speedway
• Disney Store Celebrates First East Coast Grand Opening of New Store Design at Roosevelt Field Mall in Garden City, NY
• Planets In Unusually Intimate Dance Around Dying Star
• LifeSource Water Softener Alternative Eliminates Bottled Water Cost and Waste, Saving Thousands of Dollars a Year
• Parsons and SCFI Group Sign Strategic Alliance Agreement